Huminig, Ayisha .

HRN: 27-31-84  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2025
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
11/27/2025
12/02/2025
ORAL
3.5ml
BID
URTI
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: